BioRestorative Therapies (BRTX)

BioRestorative Therapies (BRTX) Stock Price & Analysis


BRTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.46 - $6.33
Previous Close$5.35
Average Volume (3M)30.04K
Market Cap
Enterprise Value$8.69M
Total Cash (Recent Filing)$12.37M
Total Debt (Recent Filing)$268.36K
Price to Earnings (P/E)-1.0
May 15, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.28
Shares Outstanding3,887,615
10 Day Avg. Volume23,018
30 Day Avg. Volume30,037
Standard Deviation22.00
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)664.50
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue64.35
Enterprise Value/Gross Profit72.56
Enterprise Value/Ebitda-1.10
Price Target Upside12.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1




What was BioRestorative Therapies’s price range in the past 12 months?
BioRestorative Therapies lowest stock price was $2.46 and its highest was $6.33 in the past 12 months.
    What is BioRestorative Therapies’s market cap?
    Currently, no data Available
    When is BioRestorative Therapies’s upcoming earnings report date?
    BioRestorative Therapies’s upcoming earnings report date is May 15, 2018 which is 1846 days ago.
      How were BioRestorative Therapies’s earnings last quarter?
      Currently, no data Available
      Is BioRestorative Therapies overvalued?
      According to Wall Street analysts BioRestorative Therapies’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does BioRestorative Therapies pay dividends?
        BioRestorative Therapies does not currently pay dividends.
        What is BioRestorative Therapies’s EPS estimate?
        BioRestorative Therapies’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does BioRestorative Therapies have?
        BioRestorative Therapies has 3,887,615 shares outstanding.
          What happened to BioRestorative Therapies’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of BioRestorative Therapies?
          Currently, no hedge funds are holding shares in BRTX


          BioRestorative Therapies Stock Smart Score

          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          BioRestorative Therapies

          Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. The ThermoStem Program focuses on treatments for metabolic disorders and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. It also offers plant stem cell-based facial creams and products under the Stem Pearls brand. Biorestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.


          Top 5 ETFs holding BRTX

          Market Value
          Smart Score
          Vanguard Total Stock Market ETF
          Up to five ETFs with an Outperform Smart Score that hold BRTX. The ETFs are listed according to market value of BRTX within the ETF


          Forecast EPS vs Actual EPS

          Similar Stocks
          Price & Change
          Brainstorm Cell Therapeutics

          Popular Stocks

          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis